Ataxin-3

BE0013512ProteinHumansATXN3

Deubiquitinating enzyme involved in protein homeostasis maintenance, transcription, cytoskeleton regulation, myogenesis and degradation of misfolded chaperone substrates (PubMed:12297501, PubMed:16118278, PubMed:17696782, PubMed:23625928, PubMed:28445460, PubMed:33157014). It is acted on by 1 drug in DrugBank.

Gene name
ATXN3
UniProtKB entry
P54252Swiss-Prot
Cellular location
Nucleus matrix
Residues / weight
361 residues · 41,250 Da
Also known as
3.4.19.12 · ATX3 · Machado-Joseph disease protein 1 · MJD · MJD1

Resolves to

Protein
UniProtP54252UniProt nameATX3_HUMAN
Gene
HGNCHGNC:7106NCBI Gene4287GeneCardsATXN3
Pharmacology
KEGGhsa:4287
Structure
PDB1YZBPDB2AGAPDB2DOS
Drugs

What you can answer from here — as of September 03, 2024

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
37GO termsFunction, process and component, as structured annotations
Sign in
3Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which compounds in development act on Ataxin-3, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In